Halftime Report Panelist 2

Crypto Analyst, CoinDesk
· tracked since Aug 2026
Calls
1
Win Rate
0.0%
return
-0.2%
Calls 1 1 Posts tracked · 1.0/day Posted today
Calls
7d 1
30d 1
90d 1
Best Calls
No live winners yet
Worst Calls
BMY Long -0.2%
Most Mentioned
BMY ×1
Recent Calls
BMY Long 9 hours ago
Win Rate 0% Long 1 Short 0
Win Rate
7d
30d
90d
Average Return -0.2% Long Return -0.2% Short Return -
Average Return
7d
30d
90d
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 04
$65.95
-0.2%
Cheap, dividend, pipeline complements oncology.
Bristol-Myers Squibb is exceptionally cheap, has a good dividend yield, and possesses a pipeline that complements AstraZeneca’s oncology focus, particularly in cardiovascular, despite the negative market reaction to the rumored deal.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions

Halftime Report Panelist 2 has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026. Most covered: BMY.